Morgan Stanley Maintains Overweight on Danaher, Raises Price Target to $240

10/13/2026
Impact: 75
Healthcare

Morgan Stanley analyst Kallum Titchmarsh has maintained an Overweight rating on Danaher (NYSE: DHR) and raised the price target from $220 to $240. This adjustment reflects a positive outlook on the company's performance.

AI summary, not financial advice

Share: